Subscribe To
nkarta (nktx) rallies 112% as fda clears ind for lupus drug
nkarta (NKTX) rallies 112% on FDA nod to begin the clinical development of its investigational candidat...
October 18, 2023, 12:03 pm
Investor alert: abbott cooper pllc announces investigation into nkarta, inc.; urges nkarta stockholders to contact abbott cooper regarding their legal rights
STAMFORD, Conn., Oct. 13, 2023 (GLOBE NEWSWIRE) — Abbott Cooper PLLC is investigating nkarta, Inc. (N...
October 13, 2023, 2:23 pm
nkarta reports second quarter 2023 financial results and corporate highlights
NKX101 clinical update highlights encouraging antileukemic activity in patients with AML using fludarabine/cytarabine (Flu/Ara-C) lymphodepletion regi...
August 10, 2023, 11:01 am
nkarta to participate at upcoming investor conference
SOUTH SAN FRANCISCO, Calif., Aug. 03, 2023 (GLOBE NEWSWIRE) -- nkarta, Inc. (Nasdaq: NKTX), a biopharma...
August 3, 2023, 8:02 am
Here's why nkarta, inc. (nktx) is poised for a turnaround after losing -39.31% in 4 weeks
nkarta, Inc. (NKTX) is technically in oversold territory now, so the heavy selling pressure might have ...
June 28, 2023, 10:36 am
Why shares of nkarta are slumping tuesday
nkarta's lead therapy showed limited effectiveness in treating acute myeloid leukemia. Last week, there...
June 27, 2023, 1:02 pm
nkarta to host conference call to discuss updated clinical data from nkx101 nk cell therapy program
SOUTH SAN FRANCISCO, Calif., June 26, 2023 (GLOBE NEWSWIRE) -- nkarta, Inc. (Nasdaq: NKTX), a biopharma...
June 26, 2023, 4:01 pm
nkarta presents nkx019 clinical data at the european hematology association 2023 congress and 17th international conference on malignant lymphoma
7 of 10 r/r NHL patients achieved complete response (70% CR rate) following treatment with NKX019 monotherapy at 1 billion and 1.5 billion CAR NK cell...
June 10, 2023, 2:47 pm
nkarta to participate at upcoming investor conferences
SOUTH SAN FRANCISCO, Calif., April 12, 2023 (GLOBE NEWSWIRE) -- nkarta, Inc. (Nasdaq: NKTX), a biopharm...
April 12, 2023, 9:06 pm
nkarta: going down despite solid data due to fate's debacle
NKTX has consistently produced solid data from its NK cell programs. Despite that, the stock is going down....
March 26, 2023, 6:37 am
nkarta to participate at upcoming investor conferences
SOUTH SAN FRANCISCO, Calif., Feb. 09, 2023 (GLOBE NEWSWIRE) — nkarta, Inc. (Nasdaq: NKTX), a biopharm...
February 9, 2023, 1:02 pm
nkarta to participate at upcoming investor conferences
SOUTH SAN FRANCISCO, Calif., Feb. 09, 2023 (GLOBE NEWSWIRE) -- nkarta, Inc. (Nasdaq: NKTX), a biopharma...
February 9, 2023, 8:02 am
nkarta to host conference call to discuss updated clinical data from nkx019 nk cell therapy program
Call scheduled for Monday, December 5, 2022 at 8:00 a.m. ET SOUTH SAN FRANCISCO, Calif., Dec. 02, 2022 (GLOBE NEWSWIRE) — ...
December 2, 2022, 9:02 pm
nkarta to host conference call to discuss updated clinical data from nkx019 nk cell therapy program
Call scheduled for Monday, December 5, 2022 at 8:00 a.m. ET Call scheduled for Monday, December 5, 2022 at 8:00 a.m. ET...
December 2, 2022, 4:02 pm
nkarta: under the radar company with brilliant results
NKTX came out with strong data in heavily pretreated AML patients in April. Data was at least as good as Fate's data, which is valued nearly 4x higher...
November 10, 2022, 12:02 pm
nkarta stock a bargain compared to fate therapeutics
Investors who like Fate Therapeutics Inc. ( FATE , Financial) should love nkarta Inc. ( NKTX , Financia...
June 8, 2022, 5:24 pm
nkarta to participate at upcoming investor conference
SOUTH SAN FRANCISCO, Calif., May 31, 2022 (GLOBE NEWSWIRE) -- nkarta, Inc. (Nasdaq: NKTX), a biopharmac...
May 31, 2022, 7:02 am
nkarta: a promising natural killer cell play
The market has favorably appreciated nkarta's recent readout of its NKX101 and NKX019 drug candidates, ...
May 20, 2022, 3:14 pm
nkarta scores huge gain on cancer treatment results
Bargain hunters may want to feast their eyes on a South San Francisco-based biotech focusing on cancer treatments....
April 25, 2022, 5:04 pm
Here is why nkarta is 40% up
nkarta Inc. (NASDAQ: NKTX) is up 40% after announcing positive preliminary Phase 1 findings from its do...
April 25, 2022, 12:51 pm